financetom
Business
financetom
/
Business
/
Ur-Energy Plans Primary Offering; Shares Drop Premarket
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ur-Energy Plans Primary Offering; Shares Drop Premarket
Jul 26, 2024 2:55 AM

05:37 AM EDT, 07/26/2024 (MT Newswires) -- Ur-Energy ( URG ) said late Thursday that it intends to offer and sell shares in an underwritten public offering.

Shares of the company slumped more than 8% in premarket activity Friday.

The company expects to grant underwriters a 30-day option to purchase additional common stock equal to up to 15% of the securities sold in the offering.

The company will be selling all the securities in the offering.

Ur-Energy ( URG ) anticipates using the net proceeds to, among other things, supplement working capital for the continued ramp-up at Lost Creek, support development at Shirley Basin, and possible future acquisitions.

The company "frequently evaluates acquisition opportunities to expand its portfolio of uranium projects."

Price: 1.1900, Change: -0.11, Percent Change: -8.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson Controls forecasts Q1 profit above estimates on strong demand for building equipment
Johnson Controls forecasts Q1 profit above estimates on strong demand for building equipment
Nov 6, 2024
Nov 6 (Reuters) - Johnson Controls International ( JCI ) forecast first-quarter profit above Wall Street estimates on Wednesday, banking on sustained demand for building and industrial equipment from data centers. The global demand for data centers has remained resilient as more businesses integrate artificial intelligence into their offerings, benefiting companies such as Johnson Controls ( JCI ). Shares of...
Ionis Pharmaceuticals' Q3 Loss Narrows, Revenue Decreases
Ionis Pharmaceuticals' Q3 Loss Narrows, Revenue Decreases
Nov 6, 2024
08:08 AM EST, 11/06/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported a Q3 loss Wednesday of $0.95 per diluted share, narrower than the $1.03 loss a year earlier. Analysts polled by Capital IQ expected a loss of $1.16. Revenue for the quarter ended Sept. 30 was $134 million, compared with $144 million a year earlier. Analysts surveyed by...
Vertex Q3 Non-GAAP Earnings, Revenue Increase; 2024 Revenue Outlook Lifted
Vertex Q3 Non-GAAP Earnings, Revenue Increase; 2024 Revenue Outlook Lifted
Nov 6, 2024
08:12 AM EST, 11/06/2024 (MT Newswires) -- Vertex (VERX) reported Q3 non-GAAP earnings Wednesday of $0.16 per diluted share, up from $0.10 a year earlier. Analysts polled by Capital IQ expected $0.14. Revenue for the quarter ended Sept. 30 was $170.4 million, up from $145 million a year earlier. Analysts surveyed by Capital IQ expected $165.7 million. The company said...
Amicus Therapeutics Swings to Q3 Non-GAAP Net Income, Sales Gain; Raises 2024 Revenue Growth Guidance; Shares Rise Pre-Bell
Amicus Therapeutics Swings to Q3 Non-GAAP Net Income, Sales Gain; Raises 2024 Revenue Growth Guidance; Shares Rise Pre-Bell
Nov 6, 2024
08:13 AM EST, 11/06/2024 (MT Newswires) -- Amicus Therapeutics ( FOLD ) reported Q3 non-GAAP net income Wednesday of $0.10 per diluted share, compared with a loss of $0.01 a year earlier. Analysts polled by Capital IQ expected $0.05 per share. Net products sales for the quarter ended Sept. 30 were $141.5 million, up from $103.5 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved